Advertisement

Topics

Uncovering the Barriers of Colorectal Cancer Screening Amongst Siblings of Colorectal Cancer Patients.

2018-01-18 10:49:10 | BioPortfolio

Published on BioPortfolio: 2018-01-18T10:49:10-0500

Clinical Trials [2812 Associated Clinical Trials listed on BioPortfolio]

Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment

This study will evaluate the value of providing proactive behavioral (telephone counseling) and pharmacotherapy (cessation medication) treatment to current smokers as a part of participati...

A Longitudinal Study of Colorectal Cancer Patients With Metastatic Disease in Middle-Norway

The main objective is to provide original research results that may change clinical practice related to metastatic colorectal cancer. The study will evaluate treatment and patient care at ...

Proactive Tobacco Treatment for Veterans

The purpose of this research study is to assess whether a population-level proactive tobacco treatment strategy combining 1) proactive outreach and 2) choice of smoking cessation services ...

Proactive Care Coordination for Cancer Survivors Who Smoke

This is a population-based randomized controlled trial of 600 patients with a diagnosis of cancer in the past 2 years and registry indicating smoking at the time of diagnosis, that will in...

An Engagement Engine for Fitness Trackers

The iTrackFitness study aims to test the "engagement engine" that was developed from activity tracker and survey data gathered during phase I of the study. For the current phase the "engag...

PubMed Articles [26441 Associated PubMed Articles listed on BioPortfolio]

Current status of immunotherapy in metastatic colorectal cancer.

Immunotherapy focuses on selectively enhancing the host's immune response against malignant disease. It has been investigated as an important treatment modality against malignant disease for many year...

Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options.

Peritoneal metastases (PM) are common in advanced-stage colorectal cancer (CRC) patients representing the second most common metastatic site of CRC. In the past, this clinical situation was treated wi...

Potential determinants of physical inactivity among long-term colorectal cancer survivors.

Since physical activity (PA) has been shown to be associated with better prognosis and quality of life (QOL) in colorectal cancer (CRC) patients, this study focuses on the barriers of PA among CRC sur...

NOTUM Is Involved in the Progression of Colorectal Cancer.

There are limitations to current colorectal cancer (CRC)-specific diagnostic methods and therapies. Tumorigenesis proceeds because of interaction between cancer cells and various surrounding cells; di...

Reassessing the role of liver transplantation for patients with metastatic colorectal cancer to the liver.

Early studies reported poor survival rates following liver transplantation for metastatic colorectal cancer to the liver and liver transplantation has thus traditionally been contraindicated for these...

Medical and Biotech [MESH] Definitions

Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Tumor suppressor genes located in the 5q21 region on the long arm of human chromosome 5. The mutation of these genes is associated with the formation of colorectal cancer (MCC stands for mutated in colorectal cancer).

Tumor suppressor genes located in the 18q21-qter region of human chromosome 18. The absence of these genes is associated with the formation of colorectal cancer (DCC stands for deleted in colorectal cancer). The products of these genes show significant homology to neural cell adhesion molecules and other related cell surface glycoproteins.

A group of autosomal-dominant inherited diseases in which COLON CANCER arises in discrete adenomas. Unlike FAMILIAL POLYPOSIS COLI with hundreds of polyps, hereditary nonpolyposis colorectal neoplasms occur much later, in the fourth and fifth decades. HNPCC has been associated with germline mutations in mismatch repair (MMR) genes. It has been subdivided into Lynch syndrome I or site-specific colonic cancer, and LYNCH SYNDROME II which includes extracolonic cancer.

Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER.

More From BioPortfolio on "Uncovering the Barriers of Colorectal Cancer Screening Amongst Siblings of Colorectal Cancer Patients."

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial